Diana Halim
Directeur Technique/Scientifique/R&D chez KOLON TISSUEGENE, INC.
Profil
Diana M.
Halim is currently the Vice President-Clinical & Regulatory Affairs at Kolon TissueGene, Inc. She previously worked as the Director-Regulatory Affairs at AnGes, Inc. from 2008 to 2014, at Sucampo Pharmaceuticals LLC from 2014 to 2017, and at RRD International LLC from 2017 to 2019.
Ms. Halim has an undergraduate degree from George Washington University and a graduate degree from The Johns Hopkins University.
Postes actifs de Diana Halim
Sociétés | Poste | Début |
---|---|---|
KOLON TISSUEGENE, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Diana Halim
Sociétés | Poste | Fin |
---|---|---|
RRD International LLC
RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Conseiller Juridique Général | 01/12/2019 |
SUCAMPO PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/09/2017 |
ANGES, INC. | Conseiller Juridique Général | 01/09/2014 |
Formation de Diana Halim
George Washington University | Undergraduate Degree |
The Johns Hopkins University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
KOLON TISSUEGENE, INC. | Health Technology |
ANGES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
RRD International LLC
RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |